ALB Stock Analysis — Albemarle Corporation
Sector: Chemicals
AI Verdict
Albemarle looks cheap for the growth on offer at 9.6x forward earnings, but the overbought RSI means new buyers risk getting caught in a near-term correction unless its lithium moat keeps driving upside surprises.
Competitive Moat
Albemarle is a top global producer of lithium compounds essential for EV batteries, with long-term supply contracts and vertically integrated extraction-to-refining operations that are difficult for new entrants to replicate. Its scale and established relationships with automakers and battery manufacturers create switching costs and pricing power.
Summary
Albemarle's lithium business is in focus as the stock trades at just 9.6x next year's earnings despite a 59.76% one-year return.
Where It Stands
With a 59.76% one-year return and an RSI of 74.7 (overbought), Albemarle trades at 9.6x forward earnings, far below the chemicals sector median of ~20x.
Key Metrics
- RSI: 74.7 — Overbought
- Forward P/E: 9.6x
- Revenue Growth: +0.2%
- Market Cap: $15.4B
- Dividend Yield: 0.01%
- 1-Year Return: 59.76%
- 52-Week High: $221.00
- 52-Week Low: $71.25
Analyst Consensus
16 Buy · 10 Hold · 0 Sell (26 analysts)
Bull Case
A forward P/E of 9.6x with 18.3% trailing revenue growth offers a rare combination of low valuation and double-digit top-line expansion.
Bear Case
The RSI of 74.7 signals overbought conditions, so even a modest pullback to a neutral RSI could erase a chunk of the recent 59.76% gain.
Catalyst to Watch
Watch for lithium pricing updates or major contract announcements, as these could reset earnings expectations and valuation multiples.